季线金叉,月线KDJ已掉头向上,大底部持续放量,从历史最低点仅上涨一倍,待利好消息逐步释放,20倍以上目标可待。查看全文
利弗魔尔2021-03-12 02:04
$Invivo治疗控股(NVIV)$ 神经脊髓支架,这个有科技含量啊,异动,估计很快有更大动作,4000万市值,目标3倍。$苹果(AAPL)$ $特斯拉(TSLA)$查看全文
chuminhua2021-03-03 16:37
3月2日,Inovio Pharmaceuticals宣布,其基于DNA的在研HPV免疫疗法VGX-3100在一项后期试验中达到了可评估受试者的主要和次要终点,可作为与人乳头瘤病毒(HPV)相关的高级别鳞状上皮内病变(HSIL)的潜在疗法。首席执行官J.Joseph Kim提出,如果获得批准,VGX-3100有可能 "成为受HPV-16-/18相...查看全文
$InVivo Therapeutics Holdings Corp.(NVIV)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2018-01-29 AccNo: 0001104659-18-004326 Size: 14 MB 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ 8-K - Current report Filed: 2018-01-26 AccNo: 0001104659-18-004110 Size: 515 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits http:/...
$InVivo Therapeutics Holdings Corp.(NVIV)$ 8-K - Current report Filed: 2018-01-23 AccNo: 0001104659-18-003599 Size: 23 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ 10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)] Filed: 2018-01-03 AccNo: 0001558370-18-000011 Size: 335 KB 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ 8-K - Current report Filed: 2018-01-03 AccNo: 0001104659-18-000360 Size: 58 KBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ 8-K - Current report Filed: 2017-12-18 AccNo: 0001104659-17-073877 Size: 56 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officer...
$InVivo Therapeutics Holdings Corp.(NVIV)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-10-30 AccNo: 0001558370-17-007711 Size: 5 MB 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ 8-K - Current report Filed: 2017-09-26 AccNo: 0001104659-17-058747 Size: 19 KBItem 7.01: Regulation FD Disclosure 网页链接
$InVivo Therapeutics Holdings Corp.(NVIV)$ 8-K - Current report Filed: 2017-08-28 AccNo: 0001104659-17-054012 Size: 45 KBItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Cer...
$InVivo Therapeutics Holdings Corp.(NVIV)$ 8-K - Current report Filed: 2017-08-28 AccNo: 0001104659-17-054012 Size: 45 KBItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Cer...